BioCentury
ARTICLE | Company News

Management tracks

March 13, 2017 11:10 PM UTC

Antibody and anti-infective play ContraFect Corp. (NASDAQ:CFRX) said Chairman and CEO Steven Gilman will take temporary medical leave of absence. He will remain chairman, and expects to return to the CEO role in 3Q17.

Synthetic biology company Intrexon Corp. (NYSE:XON) said President Geno Germano resigned. Randal Kirk will remain chairman and CEO after canceling a plan to transition to executive chairman...